Ending tuberculosis requires more than medicine

Deaths caused by TB disproportionately affects patients in low- and middle-income countries, reflecting the role of socioeconomic factors in the management of the disease. — MSF

If someone mentions a respiratory infection that spreads through droplets and causes fever, coughing, phlegm production and fatigue, the first thing that is likely to come to mind is the SARS-CoV-2 virus that started to plague the world in 2019.

However, the same description is applicable to tuberculosis (TB), a respiratory infection that has been with us for a much longer period of time.